Telesis Bio Inc. (TBIO) vs Trinity Biotech PLC (TRIB)
Telesis Bio Inc. and Trinity Biotech PLC are both Medical Devices companies. Telesis Bio Inc. is the larger, with a market value of $5.3M against $4.5M — 1.2× the size. Trinity Biotech PLC grew revenue faster over the last twelve months: −13.5% against −38.1%. Trinity Biotech PLC has the higher net margin (−70.1% vs −287.9%) and the lower return on invested capital (−12.6% vs 0.00%). Across the 16 metrics below, Telesis Bio Inc. leads on 9 and Trinity Biotech PLC on 7.
Valuation
Profitability
| Metric | TBIO | TRIB | Medical Devices median |
|---|---|---|---|
| Gross margin | 45.62% | 39.99% | 56.01% |
| Operating margin | (265.73%) | (25.43%) | (15.03%) |
| Net margin | (287.90%) | (70.07%) | (20.40%) |
| Free cash flow margin | (143.25%) | (9.10%) | (7.24%) |
| Return on equity | 1,013.88% | 55.26% | (15.32%) |
| Return on assets | (73.87%) | (32.70%) | (19.72%) |
| Return on invested capital | 0.00% | (12.61%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack